Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?-Reference-Cited by-同舟云学术

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Published:2015-07 Issue:1 Volume:95 Page:88-104
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Wang-Lopez Qian,Chalabi Nassera,Abrial Catherine,Radosevic-Robin Nina,Durando Xavier,Mouret-Reynier Marie-Ange,Benmammar Kheir-Eddine,Kullab Sharif,Bahadoor Mohun,Chollet Philippe,Penault-Llorca Frédérique,Nabholtz Jean-Marc

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference87 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci U S A,2001

4. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype;Cheang;Clin Cancer Res,2008

5. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma;Livasy;Mod Pathol,2006

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity;Breast Cancer Research;2024-05-14

2. Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer;Journal of Breast Cancer;2024

3. Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system;Discover Oncology;2023-10-24

4. Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study;Frontiers in Oncology;2023-10-02

5. Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival;Gynecologic Oncology;2023-10